Shanghai ZJ Bio-Tech Co. Ltd. A - Asset Resilience Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has an Asset Resilience Ratio of 9.38% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Shanghai ZJ Bio-Tech Co. Ltd. A's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shanghai ZJ Bio-Tech Co. Ltd. A total assets.
Liquid Assets Composition Over Time
This chart breaks down Shanghai ZJ Bio-Tech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Shanghai ZJ Bio-Tech Co. Ltd. A for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥342.94 Million | 9.38% |
| Total Liquid Assets | CN¥342.94 Million | 9.38% |
Asset Resilience Insights
- Limited Liquidity: Shanghai ZJ Bio-Tech Co. Ltd. A maintains only 9.38% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai ZJ Bio-Tech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai ZJ Bio-Tech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Shanghai ZJ Bio-Tech Co. Ltd. A (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Shanghai ZJ Bio-Tech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.24% | CN¥347.89 Million ≈ $50.91 Million |
CN¥3.76 Billion ≈ $550.76 Million |
+6.60pp |
| 2014-12-31 | 2.64% | CN¥5.28 Million ≈ $772.52K |
CN¥199.63 Million ≈ $29.21 Million |
-- |
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. The company offers nucleic acid and real-time PCR kits, as well as consumables. It serves public health safety and clinical diagnostics sectors. The company was founded in 2005 and is based in Shanghai, China.